Patient Square Capital LP Pharvaris N.V. Transaction History
Patient Square Capital LP
- $277 Billion
- Q2 2025
A detailed history of Patient Square Capital LP transactions in Pharvaris N.V. stock. As of the latest transaction made, Patient Square Capital LP holds 244,283 shares of PHVS stock, worth $5.37 Million. This represents 1.55% of its overall portfolio holdings.
Number of Shares
244,283
Previous 245,496
0.49%
Holding current value
$5.37 Million
Previous $3.85 Billion
11.55%
% of portfolio
1.55%
Previous 1.59%
Shares
4 transactions
Others Institutions Holding PHVS
# of Institutions
58Shares Held
39.2MCall Options Held
0Put Options Held
0-
General Atlantic LLC New York, NY7.53MShares$166 Million4.61% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA4.41MShares$96.9 Million85.48% of portfolio
-
Ven Bio Partners LLC San Francisco, CA4.29MShares$94.3 Million79.45% of portfolio
-
Viking Global Investors LP3.65MShares$80.3 Million0.2% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA3.3MShares$72.6 Million17.44% of portfolio
About Pharvaris N.V.
- Ticker PHVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,766,000
- Market Cap $742M
- Description
- Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...